scispace - formally typeset
S

S. Palkonen

Publications -  29
Citations -  5665

S. Palkonen is an academic researcher. The author has contributed to research in topics: European union & Asthma. The author has an hindex of 21, co-authored 29 publications receiving 5144 citations.

Papers
More filters
Journal ArticleDOI

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Jean Bousquet, +95 more
- 01 Apr 2008 - 
TL;DR: The ARIA guidelines for the management of allergic rhinitis and asthma are similar in both the 1999 ARIA workshop report and the 2008 Update as discussed by the authors, but the GRADE approach is not yet available.
Journal ArticleDOI

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Jean Bousquet, +236 more
TL;DR: Ten years after the publication of the ARIA World Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children.
Journal ArticleDOI

MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine

Jean Bousquet, +72 more
- 01 May 2011 - 
TL;DR: MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine 2011; 66: 596–604.
Journal ArticleDOI

The Brussels Declaration: the need for change in asthma management.

TL;DR: The present paper reviews the evidence supporting the need for change in asthma management and summarises the ten key points contained in the Brussels Declaration.
Journal ArticleDOI

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

Jean Bousquet, +541 more
TL;DR: The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status.